Lightstone Ventures

Investment thesis

Backs founders developing breakthrough therapeutics and disruptive medtech, spanning small molecules, biologics and cell/gene therapies across CNS, immunology, oncology and ophthalmology, plus device and personalized-medicine platforms. Team carries the Morgenthaler/ATV life-sciences lineage.

Notable portfolio

Sector focus